FDA Authorizes New At-Home Rapid COVID-19 Test, Expects Capacity to Double in US

A sign for the Food and Drug Administration is seen outside of the headquarters in White Oak, Maryland, on July 20, 2020. Sarah Silbiger/Getty Images

The Food and Drug Administration (FDA) said Monday it authorized a new over-the-counter COVID-19 rapid antigen test that “is expected to double rapid at-home testing capacity in the U.S. over the next several weeks.”

The FDA’s emergency use authorization is for the ACON Laboratories Flowflex COVID-19 Home Test, which can be used at home without a prescription.